Timo Krings

Timo Krings is a German neuroradiologist known for his contributions to the fields of diagnostic and interventional neuroradiology.

He is currently the chair of the Division of Neurointerventional Radiology and director of the Neurovascular Center at the Lahey Clinic and Beth Israel Lahey Health in Boston and a full professor of radiology at UMass Chan School of Medicine.

He received the Anderson Award from the Wightman-Berris Academy for his work to the development of the Neuroradiology Program in Toronto. Additionally, he was awarded with the Edward Lansdown Award for his work in University of Toronto.

Biography He was born and educated in Germany. He studied medicine at RWTH Aachen University and continued his training in Neuroradiology under Armin Thron at University Hospital Aachen.

His educational path included additional training at Harvard Medical School In 2008, he joined the University of Toronto, where he was Site Chief of Medical Imaging at the Toronto Western Hospital, Division Head of Diagnostic and Interventional Neuroradiology and held the David Braley and Nancy Gordon Chair in Interventional Neuroradiology until 2024 when he joined the Lahey Clinic in Boston, USA.

Scientific career His research is focused on imaging and treatment for conditions such as brain aneurysms, arteriovenous malformations, and stroke. He has contributed to methods that help predict and prevent brain bleeding from vascular malformations.

He collaborates with Texas Children's Hospital and researchers like Karen Chen to advance fetal brain surgery for treating vein of Galen malformations. This work involves investigating innovative approaches to improve outcomes in affected infants, with ongoing trials contributing to the rapidly evolving field.

He has researched to the study of genetic factors associated with brain arteriovenous malformations (BAVMs), collaborating with Ivan Radovanovic and Jason Fish at the University Health Network (UHN), he has explored the role of the KRAS gene, which is implicated in both cerebrovascular conditions and certain cancers; this research examines the potential application of existing cancer therapies to modulate the genetic pathways of BAVMs.

By developing and studying preclinical models with altered KRAS expression, Krings and his colleagues aim to identify novel therapeutic strategies for this challenging condition.

Krings is involved in the organization of multiple teaching courses including the Interventional Neuroradiology Symposium and the Canadian Neuroradiology Course.

Krings has published over 450 internationally peer reviewed articles that have accumulated over 29,000 citations, with an H Index of 89 and authored several books and book chapters on neurovascular imaging and interventional neuroradiology.

Selected publications

Journals

Books